Orchestra BioMed Holdings, Inc. (OBIO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -22.17M | -2.27M | -14.55M | -15.53M | -16.62M | -13.54M | -13.7M | -10.21M | -13.11M | -10.97M | -10.28M | -10.49M |
| Operating CF Margin % | -20152.73% | -7.34% | -1689.9% | -1857.3% | -1914.29% | -5350.99% | -1388.04% | -1311.83% | -2115.16% | -4188.55% | -2453.94% | -1146.45% |
| Operating CF Growth % | -33.41% | 83.23% | -6.2% | -52.14% | -26.7% | -23.36% | -33.24% | 2.71% | 8.81% | -25.5% | -127.43% | -15.41% |
| Net Income | -20.69M | 6.25M | -20.83M | -19.36M | -18.75M | -16.16M | -15.43M | -15.98M | -13.46M | -12.82M | -13.32M | -12.05M |
| Depreciation & Amortization | 90K | 82K | 81K | 81K | 83K | 84K | 76K | 74K | 74K | 72K | 71K | 231K |
| Stock-Based Compensation | 0 | 2.75M | 3.01M | 3.25M | 2.96M | 2.9M | 2.36M | 2.76M | 2.59M | 919K | 3.51M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.08M | 0 | 0 |
| Other Non-Cash Items | 2.1M | 934K | 643K | 147K | 81K | 994K | 523K | -132K | -479K | 2.05M | -1.16M | 713K |
| Working Capital Changes | -3.66M | -12.28M | 2.54M | 358K | -990K | -1.36M | -1.24M | 3.07M | -1.83M | -116K | 613K | 612K |
| Change in Receivables | 11K | -43K | 31K | 6K | 3K | 38K | -35K | -13K | 32K | -13K | 85K | -95K |
| Change in Inventory | 33K | 55K | -181K | -49K | 38K | 60K | -164K | 45K | 31K | -8K | 41K | 54K |
| Change in Payables | -3.06M | 0 | 0 | 0 | 0 | 0 | 4.96M | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 10.32M | -17.71M | -38.58M | 16.36M | 13M | -3.75M | 557K | 10.42M | 5.86M | 33.15M | 12.95M | 8.12M |
| Capital Expenditures | -184K | -33K | -310K | -34K | -112K | -106K | -68K | -107K | -8K | 3K | -19K | -27K |
| CapEx % of Revenue | 167.27% | 0.11% | 36% | 4.07% | 12.9% | 41.9% | 6.89% | 13.75% | 1.29% | 1.15% | 4.53% | 2.95% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | -602K | 0 | 0 | 0 | -33.15M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.15M | 0 | 0 |
| Cash from Financing | 5.53M | 12.66M | 76.4M | -428K | -296K | 13.95M | 15.04M | 171K | 18K | -10.7M | 4K | 86K |
| Debt Issued (Net) | 0 | -972K | 18.89M | 0 | 0 | 15M | 0 | 0 | 0 | -10.85M | 0 | 0 |
| Equity Issued (Net) | 5.88M | 14.1M | 57.78M | -428K | 91K | 51K | 15.04M | 171K | 18K | 153K | 4K | 86K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -428K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -354K | -468K | -269K | 0 | -387K | -1.1M | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -6.32M | -7.32M | 23.26M | 401K | -3.91M | -3.34M | 1.89M | 389K | -7.24M | 11.48M | 2.67M | -2.29M |
| Free Cash Flow | -22.35M | -2.3M | -14.86M | -15.56M | -16.73M | -13.64M | -13.77M | -10.31M | -13.12M | -10.97M | -10.3M | -10.52M |
| FCF Margin % | -20320% | -7.45% | -1725.9% | -1861.36% | -1927.19% | -5392.89% | -1394.93% | -1325.58% | -2116.45% | -4187.4% | -2458.47% | -1149.4% |
| FCF Growth % | -33.62% | 83.12% | -7.93% | -50.89% | -27.48% | -24.36% | -33.66% | 1.94% | 8.98% | -24.7% | -117.09% | -12.42% |
| FCF per Share | -0.58 | -0.06 | -0.39 | -0.41 | -0.44 | -0.36 | -0.37 | -0.29 | -0.37 | -0.31 | -0.29 | -0.30 |
| FCF Conversion (FCF/Net Income) | 1.07x | -0.36x | 0.70x | 0.80x | 0.89x | 0.84x | 0.89x | 0.64x | 0.97x | 0.86x | 0.77x | 0.87x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |